AC
Armistice Capital Portfolio holdings
AUM
$2.64B
1-Year Return
0.99%
This Quarter Return
+15.01%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$1.22B
AUM Growth
+$304M
(+33%)
Cap. Flow
+$125M
Cap. Flow
% of AUM
10.27%
Top 10 Holdings %
Top 10 Hldgs %
43.34%
Holding
94
New
24
Increased
23
Reduced
14
Closed
27
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
$55.8M |
| 2 |
Madrigal Pharmaceuticals
MDGL
|
$53.2M |
| 3 |
Pacira BioSciences
PCRX
|
$40.8M |
| 4 |
Biogen
BIIB
|
$35.5M |
| 5 |
Burlington
BURL
|
$31.3M |
Top Sells
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$72.9M |
| 2 |
SGI
Somnigroup International Inc.
SGI
|
$34.1M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
$31.5M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$26.1M |
| 5 |
Voyager Therapeutics
VYGR
|
$24.9M |
Sector Composition
| 1 | Healthcare | 53.85% |
| 2 | Consumer Discretionary | 17.72% |
| 3 | Consumer Staples | 10.23% |
| 4 | Industrials | 7.48% |
| 5 | Communication Services | 0.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
PTC Therapeutics
PTCT
$4.55B
| $15.1M | 0.82% |
400,000
+100,000
| +33% | +$3.76M |
|
27
Dick's Sporting Goods
DKS
$17.7B
| $14.7M | 0.81% |
+400,000
| New | +$14.7M |
|
28
National Beverage
FIZZ
$3.75B
| $14.3M | 0.78% |
+496,000
| New | +$14.3M |
|
|
CLLS
29
Cellectis
CLLS
$269M
| $13.4M | 0.73% |
728,000
+139,000
| +24% | +$2.55M |
|
30
Campbell Soup
CPB
$10.1B
| $12.7M | 0.69% |
+332,000
| New | +$12.7M |
|
|
SBBP
31
DELISTED
Strongbridge Biopharma plc.
SBBP
| $12.4M | 0.68% |
2,492,000
-386,000
| -13% | -$1.92M |
|
32
J.M. Smucker
SJM
$12B
| $11.7M | 0.64% |
100,000
-140,000
| -58% | -$16.3M |
|
|
PRTK
33
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $11.4M | 0.62% |
2,124,000
+156,000
| +8% | +$836K |
|
|
BLUE
34
DELISTED
bluebird bio
BLUE
| $10.7M | 0.59% |
+5,250
| New | +$10.7M |
|
35
Cedar Fair
FUN
$2.53B
| $10.5M | 0.58% |
200,000
+50,000
| +33% | +$2.63M |
|
36
Jack in the Box
JACK
$386M
| $9.73M | 0.53% |
+120,000
| New | +$9.73M |
|
37
Nike
NKE
$109B
| $9.1M | 0.5% |
+108,000
| New | +$9.1M |
|
38
Five Below
FIVE
$8.46B
| $8.95M | 0.49% |
72,000
+12,000
| +20% | +$1.49M |
|
39
Catalyst Pharmaceutical
CPRX
$2.48B
| $7.75M | 0.42% |
1,520,000
+140,000
| +10% | +$714K |
|
40
Merck
MRK
$212B
| $7.59M | 0.42% |
+94,320
| New | +$7.59M |
|
|
ACHN
41
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $7.4M | 0.41% |
2,500,000
-1,800,000
| -42% | -$5.33M |
|
|
ALIM
42
DELISTED
Alimera Sciences, Inc.
ALIM
| $7.35M | 0.4% |
462,400
| – | – |
|
43
Brinker International
EAT
$7.04B
| $7.28M | 0.4% |
+164,000
| New | +$7.28M |
|
44
Amazon
AMZN
$2.48T
| $7.12M | 0.39% |
+80,000
| New | +$7.12M |
|
45
Ollie's Bargain Outlet
OLLI
$8.18B
| $6.83M | 0.37% |
80,000
-28,000
| -26% | -$2.39M |
|
|
VLRX
46
DELISTED
VALERITAS HOLDINGS INC
VLRX
| $6.49M | 0.36% |
995,000
+2,500
| +0.3% | +$16.3K |
|
|
RNTX
47
Rein Therapeutics, Inc. Common Stock
RNTX
$31M
| $6.31M | 0.35% |
+161,692
| New | +$6.31M |
|
48
Larimar Therapeutics
LRMR
$337M
| $5.78M | 0.32% |
175,667
+70,834
| +68% | +$2.33M |
|
49
Spotify
SPOT
$146B
| $5.55M | 0.3% |
+40,000
| New | +$5.55M |
|
50
Dropbox
DBX
$8.06B
| $5.45M | 0.3% |
+250,000
| New | +$5.45M |
|